Literature DB >> 19359824

Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.

M Lanzafame1, S Ferrari, E Lattuada, F Corsini, R Deganello, S Vento, E Concia.   

Abstract

We describe the clinical course of an HIV-infected patient with progressive multifocal leukoencephalopathy who took mirtazapine for his depression. After six months of therapy the clinical symptoms had not worsened and the neuroradiological image of the brain was unchanged. Further studies are necessary to determine the effect of serotonin receptor antagonist in treating PML associated to HIV.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19359824

Source DB:  PubMed          Journal:  Infez Med        ISSN： 1124-9390


  15 in total

Review 1.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 2.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

Review 3.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?

Authors:  S Mornese Pinna; E Scarvaglieri; M G Milia; D Imperiale; V Ghisetti; S Audagnotto; A Prochet; F Lipani; S Bonora; G Di Perri; A Calcagno
Journal:  J Neurovirol       Date:  2017-07-05       Impact factor: 2.643

Review 5.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

6.  Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.

Authors:  P Ripellino; C Comi; M Mula; C Varrasi; A Conconi; A Stecco; D Brustia; N Nasuelli; K Savio; L De Paoli; R Cantello; G Gaidano; F Monaco
Journal:  BMJ Case Rep       Date:  2011-04-15

7.  The Benefit of Mirtazapine in the Treatment of Progressive Multifocal Leukoencephalopathy in a Young HIV-positive Patient: A Case Report.

Authors:  Carola Mullins; Jorge Miranda; Hugo Sandoval; Luis Ramos-Duran; Silvina B Tonarelli
Journal:  Innov Clin Neurosci       Date:  2018-02-01

Review 8.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 9.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

10.  Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation.

Authors:  Hitoshi Yoshida; Kenji Ohshima; Jun Toda; Shinsuke Kusakabe; Hiroaki Masaie; Toshinari Yagi; Jun Ishikawa
Journal:  Int J Hematol       Date:  2013-11-22       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.